SCHEMBL4473780

SCHEMBL4473780

O=Cc1cccc(OOCc2ccccc2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 8/20 0.71
MAOB P27338 8/20 0.71
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
CCNB2 O95067 1/20 0.52
CDK1 P06493 1/20 0.52
CDK4 P11802 1/20 0.52
CCNB1 P14635 1/20 0.52
CCND1 P24385 1/20 0.52
CCNB3 Q8WWL7 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
PKM P14618 1/20 0.48
LCK P06239 1/20 0.48
TLR4 O00206 1/20 0.46
TLR2 O60603 1/20 0.46
SRC P12931 1/20 0.45
CYP2A6 P11509 1/20 0.41
BCHE P06276 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29454637 0.83 MAOB (1.00) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL314161 0.83 MAOB (1.00) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL14202654 0.82 MAOB (0.53) MAOAMAOBLCKBCHE
SCHEMBL6957202 0.81 MAOB (0.50) MAOAMAOBRAB9AALDH1A1KDM4E
SCHEMBL8585674 0.78 MAOB (0.88) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL20816026 0.78 MAOA (0.77) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL11224860 0.77 MAOA (0.80) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL1662622 0.77 MAOA (0.75) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL3083923 0.77 MAOA (0.81) MAOAMAOBNPC1RAB9ACCNB2
SCHEMBL194419 0.76 TSHR (0.52) MAOAMAOBRAB9AALDH1A1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022021981-A1 DI-(BENZIMIDAZOLE)-1, 2, 3-TRIAZOLE DERIVATIVE AND PREPARATION THEREFOR AND USE THEREOF 中南大学湘雅二医院 2022-02-03 WO disclosed
US-7598286-B2 [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones WYETH (US) 2009-10-06 US disclosed
US-20060106084-A1 [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones WYETH (US) 2006-05-18 US disclosed
WO-2006050006-A2 ((1H-INDAZOL-3-YL)METHYL) PHENOLS AND (HYDROXYPHENYL)(1H-INDAZOL-3-YL) METHANONES AS LIGANDS OF THE ESTROGEN RECEPTOR WYETH (US) 2006-05-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106084-A1 [(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones PTGS1, NOS3, PTGIS MAOA 1887/4885MAOB 2228/4885NPC1 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.